^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

SPAM1 (Sperm Adhesion Molecule 1)

i
Other names: SPAM1, Sperm Adhesion Molecule 1, SPAG15, HYAL5, PH-20, Sperm Adhesion Molecule 1 (PH-20 Hyaluronidase, Zona Pellucida Binding), Hyaluronoglucosaminidase PH-20, Sperm Surface Protein PH-20, PH-20 Hyaluronidase, Hyaluronidase PH-20, Hyal-PH20, HYAL3, PH20, Epididymis Secretory Sperm Binding Protein Li 96n, HEL-S-96n, HYAL1, HYA1
Associations
Trials
3d
Potency-enhancing mutations in E3-19K and i-leader increase the cytolytic activity of the PH20/SPAM1-armed oncolytic adenovirus Ad5Δ24RGD. (PubMed, Mol Ther Oncol)
In some cell lines, the fiber modification F5RGD10(2C) or verapamil treatment further improves actual spread efficiency. Nelfinavir inhibits spread and plaque formation of oncolytic adenoviruses with the 19KSS-iLQ125Ter modifications, irrespective of adenovirus death protein (ADP) expression...We identified an insertion site downstream of the L3-23K region that supports relatively high hPH20 activity while preserving the enhanced oncolytic potency of the virus. Combining 19KSS-iLQ125Ter with hPH20 expression may potentially improve therapeutic benefit in glioma.
Journal
|
SPAM1 (Sperm Adhesion Molecule 1)
|
Viracept (nelfinavir)
10ms
Comparison of the L3-23K and L5-Fiber Regions for Arming the Oncolytic Adenovirus Ad5-Delta-24-RGD with Reporter and Therapeutic Transgenes. (PubMed, Int J Mol Sci)
However, the insertion of transgenes downstream of either region differentially and unpredictably affects the oncolytic potency of Ad5Δ24RGD, which cannot be explained by GC3% or expression level alone. Surprisingly, the expression of the human and mouse PD-1 ectodomains with 83.1% and 70.1% GC3%, respectively, does not affect cytolytic efficacy but increases the plaque size in a cell line-dependent manner.
Clinical • Journal • PD(L)-1 Biomarker • IO biomarker
|
PD-1 (Programmed cell death 1) • SPAM1 (Sperm Adhesion Molecule 1)
12ms
Establishment and characterisation of a novel canine mast cell tumour cell line (C18). (PubMed, BMC Vet Res)
In conclusion, a novel canine cutaneous MCT cell line was successfully established, in terms of its characteristics, growth behavior and interaction with PBMCs. The C18 cell line holds a potential promise for advancing studies and developing new therapeutic strategies.
Preclinical • Journal
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • HYAL4 (Hyaluronidase 4) • SPAM1 (Sperm Adhesion Molecule 1)
over1year
HMGB1/TREM2 positive feedback loop drives the development of radioresistance and immune escape of glioblastoma by regulating TLR4/Akt signaling. (PubMed, J Transl Med)
Targeting TREM2 therapy is a promising avenue for optimizing radiotherapy and immunotherapy to improve the prognosis of GBM patients.
Journal
|
CD8 (cluster of differentiation 8) • HMGB1 (High Mobility Group Box 1) • TLR4 (Toll Like Receptor 4) • SPAM1 (Sperm Adhesion Molecule 1)
over2years
Inhibition of hyaluronic acid degradation pathway suppresses glioma progression by inducing apoptosis and cell cycle arrest. (PubMed, Cancer Cell Int)
Collectively, these observations suggest that HYAL2 overexpression could promote glioma progression. Thus, treatments that disrupt HA catabolism by altering HYAL2 expression may serve as effective strategies for glioma treatment.
Journal
|
HYAL4 (Hyaluronidase 4) • HYAL1 (Hyaluronidase 1) • HYAL2 (Hyaluronidase 2) • SPAM1 (Sperm Adhesion Molecule 1)
almost3years
Therapeutic potential of engineered oncolytic virus 3020-VV13 in a pre-clinical model of hepatocellular carcinoma (LCS 2023)
Our study demonstrates the potential of 3020-VV13 as a promising therapeutic agent for HCC. The virus showed improved anti-tumoral efficacy compared to the parental virus and was able to modulate the immune responses effectively. Further development of 3020-VV13 may provide a new option for HCC therapy.
Oncolytic virus • Preclinical • PD(L)-1 Biomarker • IO biomarker
|
PD-1 (Programmed cell death 1) • SPAM1 (Sperm Adhesion Molecule 1)
|
nCounter® PanCancer IO 360™ Panel
over3years
The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer. (PubMed, J Cancer Res Clin Oncol)
In conclusion, our study shows that the hyaluronic acid system has a relevant influence on the survival of ovarian cancer patients and could therefore be considered as a possible prognostic factor.
Journal
|
HYAL4 (Hyaluronidase 4) • HAS2 (Hyaluronan Synthase 2) • SPAM1 (Sperm Adhesion Molecule 1)
|
cisplatin • paclitaxel